ABCG2 and non-small cell lung carcinoma: The increase in ABCG2 expression in NSCLC culture TR107 following treatment with alectinib, ceritinib, dabrafenib, erlotinib, and nintedanib highlights the unique response of this specific culture and illustrates the patient-dependent nature of drug-induced changes in ABC transporter expression.